Comparison of children and coronary heart disease patients with low high density lipoprotein cholesterol levels

Atherosclerosis

Volumn 137, Issue 2, 1998, Pages 321-328

  Ohta, Takao ^a   Saku, Keijiro ^b   Nakamura, Rie ^a   Maung, Kyu Kyu ^a   Matsuda, Ichiro ^a  

^a KUMAMOTO UNIV SCHOOL OF MEDICINE   (Japan)

^b FUKUOKA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Apolipoprotein profile; Coronary heart disease; Dyslipidemic children; High density lipoprotein cholesterol; Obese children; Physicochemical characteristics of HDL

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ADOLESCENT; ADULT; ARTICLE; ATHEROSCLEROSIS; CHILD; CHOLESTEROL ESTERIFICATION; CONTROLLED STUDY; DYSLIPIDEMIA; FEMALE; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; OBESITY; PHYSICAL CHEMISTRY; PRIORITY JOURNAL;

ADOLESCENT; ADULT; APOLIPOPROTEINS A; APOLIPOPROTEINS B; CHILD; CHILD, PRESCHOOL; CHOLESTEROL, HDL; CORONARY DISEASE; FEMALE; HUMANS; HYPERLIPIDEMIAS; IMMUNODIFFUSION; MALE; OBESITY; RISK FACTORS;

EID: 18744432921     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(97)00289-X     Document Type: Article

References (22)

1. Miller NE. Association of high-density lipoprotein subclasses and apolipoproteins with ischemic heart disease and coronary atherosclerosis. Am Heart J. 113:1987;589-597.
2. Goldon DJ, Rifkind BM. High density lipoprotein: the clinical implications of recent studies. New Engl J Med. 321:1989;1311-1316.
3. Schaefer EJ, Zech LA, Schwartz DE, Brewer HB Jr. Coronary heart disease prevalence and other clinical features in familial high-density lipoprotein deficiency (Tangier disease). Ann Intern Med. 93:1980;261-266.
4. Norum KR, Gjone E, Glomset JA. Familial lecithin: cholesterol acyltransferase deficiency including fish eye disease. Scriver CR, Beaudet AL, Sly WS, Valle D The Metabolic Basis of Inherited Disease. 6th:1989;1181-1194 McGraw-Hill, New York.
5. Rader DJ, Ikewaki K, Duverger N, Feuerstein I, Zech L, Conner W, Brewer HB Jr. Very low high-density lipoproteins without coronary atherosclerosis. Lancet. 342:1993;1455-1458.
6. Takata K, Saku K, Ohta T et al. A new case of apolipoprotein (apo) A-I deficiency showing codon 8 nonsense mutation of the apo A-I gene, without evidence of coronary heart disease. Arterioscler Thromb Vasc Biol. 15:1995;1866-1874.
7. Ohta T, Saku K, Takata K, Nakamura R, Ikeda Y, Matsuda I. Different effects of subclasses of HDL containing apo A-I but not apo A-II (LpA-I) on cholesterol esterification in plasma and net cholesterol efflux from foam cells. Arterioscler Thromb Vasc Biol. 15:1995;956-962.
8. Dobiasova M, Stribrna J, Sparks DL, Pritchard PH, Frohlich JJ. Cholesterol esterification rates in very low density lipoprotein- and low density lipoprotein-depleted plasma. Relation to high density lipoprotein subspecies, sex, hyperlipidemia, and coronary heart disease. Arterioscler Thromb. 11:1991;64-70.
9. Dobiasova M, Frohlich JJ. Structural and functional assessment of HDL heterogeneity. Clin Chem. 40:1994;1554-1558.
10. Ohta T, Kakiuti Y, Kurahara K, Saku K, Nagata N, Matsuda I. Fractional esterification rate of cholesterol in high density lipoprotein is correlated with low density lipoprotein particle size in children. J Lipid Res. 38:1997;139-146.
11. Bertiere MC, Fumeron F, Rigaud D, Malon D, Apfelbaum M, Girard-Globa A. Low high density lipoprotein-2 concentrations in obese male subjects. Atherosclerosis. 73:1988;57-61.
12. Bellu R, Ortisi MT, Scaglioni S, Agostoni C, Riva E, Giovannini M. Lipid and apolipoprotein A-I and B levels in obese school-age children: results of a study in the Milan area. J Pediatr Gastroenterol Nutr. 16:1993;446-450.
13. Nakamura R, Ohta T, Migita M et al. Mass screening to identify babies with dyslipidemia by measuring the levels of apo A-I, apo B and the ratio of apo A-I to apo B on dried blood spots. Screening. 1:1992;17-25.
14. Ohta T, Nakamura R, Ikeda Y, Hattori S, Matsuda I. Follow up study on children with dyslipidemia detected by mass screening at 18 months of age: effect of 12 months dietary treatment. Eur J Pediatr. 152:1993;939-943.
15. Ohta T, Matsuda I. Lipid and apolipoprotein levels in patients with nephrotic syndrome. Clin Chim Acta. 117:1981;133-143.
16. Goto Y, Akanuma Y, Harano Y et al. Determination by SRID methods of normal values of serum apolipoprotein (A-I, A-II, B, C-II, C-III, and E) in normolipidemic healthy Japanese subjects. J Clin Biochem Nutr. 1:1986;73-88.
17. Burnstein M, Scholnick HR, Morfin R. Rapid method for the isolation of lipoproteins from human serum by precipitation with polyanions. J Lipid Res. 11:1970;583-595.
18. Warnick GR, Nguyen T, Albers AA. Comparison of improved precipitation methods for quantification of high density lipoprotein cholesterol. Clin Chem. 31:1985;217-222.
19. Ohta T, Hattori S, Nishiyama S, Matsuda I. Studies on the lipid and apolipoprotein compositions of two species of apo A-I containing lipoproteins in normolipidemic males and females. J Lipid Res. 29:1988;721-728.
20. Ohta T, Hattori S, Murakami M, Nishiyama S, Matsuda I. Age and sex-related differences in lipoproteins containing apoprotein A-I. Arteriosclerosis. 9:1989;90-95.
21. Nakamura R, Ohta T, Ikeda Y, Matsuda I. LDL inhibits the mediation of cholesterol efflux from macrophage foam cells by apo A-I-containing lipoproteins. A putative mechanism for foam cell formation. Arterioscler Thromb. 13:1993;1307-1316.
22. Kerry WS, Ohnishi T, Yokoyama S. Triglyceride transfer is required for net cholesteryl ester transfer between lipoproteins in plasma by lipid transfer protein. Evidence for a hetero-exchange transfer mechanism demonstrated by using novel monoclonal antibodies. J Biol Chem. 269:1994;28206-28213.